AdvtAdvtBy ,ETHealthWorldJoin the community of 2M+ industry professionals Subscribe to our newsletter to get latest insights & analysis. "Indian manufacturers, especially Contract Development and Manufacturing Organizations (CDMOs), are well-positioned to benefit from policies like the Biosecure Act, which encourages sourcing pharmaceuticals and APIs outside China. However, the anti-China stance could offer long-term opportunities for these sectors as American firms seek new global partnerships. "Indian CDMO companies are preparing to take advantage of these shifts by investing in advanced manufacturing technologies and expanding production capacities. "India plays a pivotal role in the U.S. healthcare system by supplying affordable, quality-assured medicines.

Source: Economic Times November 08, 2024 03:58 UTC